Chikara Οhyama

机构：Hirosaki University · ORCID：0000-0003-1550-8379

发表论文 978 篇 · 总被引 13339 次 · h-index 52

代表论文

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial (2025 · The Lancet · 被引 70)
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real‐World Multicenter Study (2025 · International Journal of Urology · 被引 12)
Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma (2025 · Scientific Reports · 被引 9)
Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy (2025 · Cancer Medicine · 被引 9)
Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer (2024 · Cancer Medicine · 被引 9)
Effects of Robot‐Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle‐Invasive Bladder Cancer: A Multicenter Retrospective Study (2025 · International Journal of Urology · 被引 7)